High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.

SARS-CoV-2 and respiratory syncytial virus continue to cause significant morbidity and mortality in the US, particularly among infants and older adults, underscoring the importance of vaccination, ...

The 2025 Interdisciplinary Research Grant (IRG) for Convergent Innovation is designed to contribute to CUNY’s goal of amplifying the quantity and quality of engaged public impact research and ...

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

Machine learning reveals unique COVID vaccine immune signatures in people living with HIV, with differences in antibodies, cytokines, and T cell responses.

Moderna’s Omicron-adapted COVID-19 vaccines appear to reduce the risk of hospitalization and death in adults who are not ...

Large-scale evolutionary analysis shows most zoonotic viruses emerge without prior adaptation, while passing through a laboratory leaves detectable genetic signatures, offering a new tool to interpret ...

Objective To present updated integrated safety analyses of bimekizumab in patients with axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA). Methods Safety data pooled from six phase IIb/III ...

Clinical outcomes were similar across different viral ARIs among inpatients with hematologic malignancy or HSCTs.

A randomized clinical trial found that metformin and ursodeoxycholic acid (UDCA) did not improve recovery rates in people ...

Although a number of studies have found that a diabetes drug called metformin reduces the risk of long COVID, new research finds that it does not reduce symptoms of the condition.

In a lawsuit challenging the legality of changes made to the country's vaccine policy, the government contends Health and Human Services Secretary Robert F. Kennedy Jr. may choose what evidence to ...